ArticleMolecular biology reports2022

Downregulation of topoisomerase 1 and 2 with acriflavine sensitizes bladder cancer cells to cisplatin-based chemotherapy.

Parisa Zargar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.